Abstract
Mangiferin is a glycosylated xanthone widely distributed in nature, which exhibits wide pharmacological activities, highlighting its anti-cancer properties. Mangiferin interferes with inflammation, lipid, and calcium signaling, which selectively inhibits multiple NFkB target genes as interleukin-6, tumor necrosis factor, plasminogen, and matrix metalloproteinase, among others. In this work, the interactions of this polyphenol with MMP-9 and NF-κβ are characterized by using computational chemistry methods. The results show MMP-9 inhibition by mangiferina is characterized for the interact with the catalytic Zn atom through a penta-coordinate structure. It is also demonstrated through a strong charge transfer established between mangiferin and Zn in the QM/MM study. Concerning the mangiferin/NF-κβ system, the 92.3% of interactions between p50 sub-unity and DNA are maintained with a binding energy of − 8.04 kcal/mol. These findings indicate that mangiferin blocks the p50-p65/DNA interaction resulting in the loss of the functions of this hetero-dimeric member and suggesting inhibition of the cancer progression.
Graphical abstract
Experimental results concerning the anti-cancer properties of mangiferin show that this natural compound can inhibit selectively MMP-9 and NF-ƙβ. Although the anti-tumor properties of mangiferin are well defined, its molecular mechanisms of actions are not described. In this work, a computational study is carried out to characterize the interactions of mangiferin with these molecular targets. The results obtained corroborate the anti-proliferative and anti-apoptotic activity of mangiferin and provide a depiction of its mechanisms of action.
Similar content being viewed by others
Data availability
The data that support the findings of this study are available from the corresponding author upon reasonable request.
Code availability
Not applicable.
References
B. Faubert, A. Solmonson, R. J. DeBerardinis, Science, 2020, 368, eaaw5473.
Malik V, Garg S, Afzal S, Dhanjal JK, Yun CO, Kaul SC, Sundar D, Wadhwa R (2020) Int J Mol Sci 21:5463
Ferlay J, Colombet M, Soerjomataram I, Parkin DM, Piñeros M, Znaor A, Bray F (2021) Int J Cancer 149:778
Dufour A, Sampson NS, Li J, Kuscu C, Rizzo RC, DeLeon JL, Zhi J, Jaber N, Liu E, Zucker S (2011) Cancer Res 71:4977
Mondal S, Adhikari N, Banerjee S, Amin SA, Jha T (2020) Eur J Med Chem 194:112260
Özdemir A, Sever B, Altıntop MD, Temel HE, Atlı O, Baysal M, Demirci F (2017) Molecules 22:1109
Sanapalli BKR, Yele V, Jupudi S, Karri VVSR (2021) RSC Adv 11:26820
Aggarwal BB, Sung B (2011) Cancer Discov 1:469
Xu L, Russu WA (2013) Bioorg Med Chem 21:540
Baldwing AS (1996) Annu Rev Immunol 14:649
Ichiki H, Miura T, Kubo M, Ishihara E, Komatsu Y, Tanikawa K, Okada M (1998) Biol Pharm Bull 21:1389
Lin H, Chen R, Liu X, Sheng F, Zhang H (2010) Spectrochim Acta, Part A 75:1584
Dar A, Faizi S, Naqvi S, Roome T, Zikr-ur-Rehman S, Ali M, Firdous S, Moin ST (2005) Biol Pharm Bull 28:596
Hernandez P, Rodriguez PC, Delgado R, Walczak H (2007) Pharmacol Res 55:167
Beltrán AE, Alvarez Y, Xavier FE, Hernanz R, Rodriguez J, Núñez AJ, Alonso MJ, Salaices M (2004) Eur J Pharmacol 499:297
Garrido G, González D, Lemus Y, Garcıa D, Lodeiro L, Quintero G, Delporte C, Núñez-Sellés AJ, Delgado R (2004) Pharmacol Res 50:143
Guha S, Ghosal S, Chattopadhyay U (1996) Chemotherapy 42:443
A. J. Núñez Selles, M. Daglia, L. Rastrelli, BioFactors, 2016, 42, 475.
Khurana RK, Kaur R, Lohan S, Singh KK, Singh B (2016) Pharm Pat Anal 5:169
Li H, Huang J, Yang B, Xiang T, Yin X, Peng W, Cheng W, Wan J, Luo F, Li H (2013) Toxicol Appl Pharmacol 272:180
Takeda T, Tsubaki M, Kino T, Yamagishi M, Lida M, Itoh T, Imano M, Tanabe G, Muraoka O, Satou T (2016) Chem-Biol Interact 251:26
Jinson G, Li L, Zian Z, Cheng X, Junjian Z (2015) Oncol Rep 33:2815
Ji-Sun J, Kangsik J, Dong-Hyun K, Hee-Sun K (2010) Pharmacol Res 66:95
M. Imran, M. Sajid Arshad, M. Sadiq Butt, J. H. Kwon, M. Umair Arshad, M. Tauseef Sultan, Lipids Health Dis. 2017, 16, 1.
Garrido G, Blanco-Molina M, Sancho R, Macho A, Delgado R, Muñoz M (2005) Phytother Res 19:211
HyperChem Professional Release v7.01 for Windows. 2002, Hypercube Inc.: Gainesville, FL.
Stewart JJ (2013) J Mol Model 19:1
W. Thiel, Theor. App. Comput. Chem. 2005, 559.
Parr RG, Yang W (1996) J Phys Chem 100:12974
DiLabio GA, Johnson ER, Otero-de-la-Roza A (2013) Phys Chem Chem Phys 15:12821
Ebadi A, Noei M (2017) J Mol Model 23:38
Peverati R (2014) D G Truhlar 372:20120476
Grimme S, Antony J, Ehrlich S, Krieg H (2010) J Chem Phys 132:154104
Marenich AV, Cramer CJ, Truhlar DG (2009) J Phys Chem 113:6378
M. J. Frisch, G. W. Trucks, H. B. Schlegel, G. E. Scuseria, M. A. Robb, J. R. Cheeseman, G. Scalmani, V. Barone, B. Mennucci, G. A. Petersson, H. Nakatsuji, M. Caricato, X. Li, H. P. Hratchian, A. F. Izmaylov, J. Bloino, G. Zheng, J. L. Sonnenberg, M. Hada, M. Ehara, K. Toyota, R. Fukuda, J. Hasegawa, M. Ishida, T. Nakajima, Y. Honda, O. Kitao, H. Nakai, T. Vreven, J. A. Montgomery, J. E. Peralta, F. Gliaro, M. Bearpark, J. J. Heyd, E. Brothers, K. N. Kudin, V. N. Staroverov, R. Kobayashi, J. Normand, K. Raghavachari, A. Rendell, J. C. Burant, S. S. Iyengar, J. Tomasi, M. Cossi, N. Rega, J. M. Millam, M. Klene, J. E. Knox, J. B. Cross, V. Bakken, C. Adamo, J. Jaramillo, R. Gomperts, R. E. Stratmann, O. Yazyev, A. J. Austin, R. Cammi, C. Pomelli, J. W. Ochterski, R. L. Martin, K. Morokuma, V. G. Zakrzewski, G. A. Voth, P. Salvador, J. J. Dannenberg, S. Dapprich, A. D. Daniels, O. Farkas, J. B. Foresman, J. V. Ortiz, J. Cioslowski,D. J Fox, Gaussian 09, Revision E.01. 2013, Gaussian, Inc.: Wallingford CT.
Stewart JJP, MOPAC2016 (2016) Stewart Computational Chemistry: Colorado Springs, CO, USA
Oreluk J, Liu Z, Hegde A, Li W, Packard A, Frenklach M, Zubarev D (2018) Sci Rep 8:13248
Reed AE, Curtiss LA, Weinhold F (1988) Chem Rev 88:899
Bhattacharjee R, Majumder T, Datta A (2019) J Comput Chem 40:1488
Sebastian S, Sundaraganesan N (2010) Spectrochim Acta, Part A 75:941
Subashchandrabose S, Krishnan AR, Saleem H, Parameswari R, Sundaraganesan N, Thanikachalam V, Manikandan G (2010) Spectrochim Acta, Part A 77:877
E. D. Glendenning, A. E. Reed, J. E. Carpenter, F. Weinhold, 2001, Gaussian Inc.: Pittsburg, PA, US.
Lu T, Chen F (2012) J Comput Chem 33:580
R. D. Dennington, T. A. Keith, J. M. Millam, 2008, GaussView 5.0. Gaussian, Inc.
Durrant JD, McCammon JA (2011) J Mol Graphics Modell 29:888
Hu X, Balaz S, Shelver WHJ (2004) J Mol Graphics Modell 22:293
Hu X, Shelver WHJ (2003) J Mol Graphics Modell 22:115
Hou X, Du J, Zhang J, Du L, Fang H, Li M (2013) J Chem Inf Model 53:188
Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, Olson AJ (2009) J Comput Chem 30:2785
Rowsell S, Maciel FV, Hawtin P, Minshull CA, Jepson H, Brockbank SMV, Barratt DG, Slater AM, McPheat WL, Waterson D, Henney AM, Pauptit RA (2002) J Mol Biol 319:173
Chen FE, Huang DB, Chen YQ, Ghosh G (1998) Nature 391:410
O’Boyle NM, Banck M, James CA, Morley C, Vandermeersch T, Hutchison GR (2011) J Cheminf 3:1
G. Klebe, H. Li, J. H. Jensen, J. E. Nielsen, P. Czodrowski, T. J. Dolinsky, N. A. Baker, Nucleic Acids Res. 2007, 35(suppl_2), W522.
J. A. McCammon, J. E. Nielsen, N. A. Baker, T. J. Dolinsky, Nucleic Acids Res. 2004, 32(suppl_2), W665.
Wang J, Wolf RM, Caldwell JW, Kollman PA, Case DA (2004) J Comput Chem 25:1157
Gasteiger J, Marsili M (1980) Tetrehaedron 36:3219
Morris GM, Goodsell DS, Halliday RS, Huey R, Hart WE, Belew RK, Olson AJ (1998) J Comput Chem 19:1639
Wang J, Wolf RM, Caldwell JW, Kollman PA, Case DA (2004) J Comput Chem 25:1157
Bayly CI, Cieplak P, Cornell W, Kollman PA (1993) J Phys Chem 97:10269
Morris GM, Goodsell DS, Halliday RS, Huey R, Hart WE, Belew RK, Olson AJ (1998) J Comput Chem 19:1639
Berendsen HJ, van der Spoel D, van Drunen R (1995) Comput Phys Commun 91:43
Lindahl E, Hess B, van Der Spoel D (2001) J Mol Mod 7:306
van Der Spoel D, Lindahl E, Hess B, Groenhof G, Mark AE, Berendsen HJ (2005) J Comput Chem 26:1701
Zhao Y, Truhlar DG (2008) Theor Chem Acc 120:215
Boys SF, Bernardi F (1970) Mol Phys 19:553
Simon S, Duran M, Dannenberg JJ (1996) J Chem Phys 105:11024
Mardirossian N, Head-Gordon M (2017) Mol Phys 115:2315
Nowroozi A, Raissi H, Hajiabadi H, Mm Jahani P (2011) Int J Quantum Chem 111:3040
Shainyan BA, Chipanina NN, Aksamentova TN, Oznobikhina LP, Rosentsveig GN, Rosentsveig IB (2010) Tetrahedron 66:8551
Sosa GL, Peruchena NM, Contreras RH, Castro EA (2002) J Mol Struct: THEOCHEM 577:209
da Veiga AA, Bragança VAN, Holanda LHC, Braga RP Jr, Sousa AC, Santos KL, Vale JK, Borges RS (2021) Chem Data Collect 31:10062
Alberts IL, Nadassy K, Wodak SJ (1998) Protein Sci 7:1700
Rouffet M, Denhez C, Bourguet E, Bohr F, Guillaume D (2009) Org Biomol Chem 7:3817
Browner MF, Smith WW, Castelhano AL (1995) Biochemistry 34:6602
Pavlovsky AG, Williams MG, Ye Q-Z, Ortwine DF, Purchase CF, White AD, Dhanaraj V, Roth BD, Johnson LL, Hupe D (1999) Protein Sci 8:1455
Yamamoto D, Takai S, Jin D, Inagaki S, Tanaka K, Miyazaki M (2007) J Mol Cell Cardiol 43:670
Tochowicz A, Maskos K, Huber R, Oltenfreiter R, Dive V, Yiotakis A, Zanda M, Bode W, Goettig P (2007) J Mol Biol 371:989
Tsai K-C, Teng L-W, Shao Y-M, Chen Y-C, Lee Y-C, Li M, Hsiao N-W (2009) Bioorg Med Chem Lett 19:5665
Shoji K, Tsubaki M, Yamazoe Y, Satou T, Itoh T, Kidera Y, Tanimori Y, Yanae M, Matsuda H, Taga A (2011) Arch Pharmacal Res 34:469
Murphy RB, Philipp DM, Friesner RA (2000) J Comput Chem 21:1442
Philipp DM, Friesner RA (1999) J Comput Chem 20:1468
Acknowledgements
The authors wish to thank the Informatic Service of InSTEC at Havana, Cuba; Raphael Pasquier, Jacques Laminie, and Pascal Poullet for their support with the calculation facilities that have been performed using Wahoo; and the cluster of the Centre Commun de Calcul Intensif of the “Université des Antilles”, Guadeloupe, France. This work received funds from the Office of Management of Funds and International Projects of the Ministry of Science, Technology and Environment of the Republic of Cuba, project PN223LH010-029.
Funding
Ministerio de Ciencia, Tecnología y Medio Ambiente (PN223LH010-029) funded this study.
Author information
Authors and Affiliations
Contributions
Conceptualization, methodology, writing — original draft, data curation, validation, supervision, writing — review and editing: UJJH; methodology, writing — original draft, calculations, data curation, writing — review and editing: AGR and AFP; writing — original draft, calculations, data curation, writing — review and editing: DR and BM; validation, supervision, writing — review and editing: ZRR and IRG.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Gálvez-Rodríguez, A., Ferino-Pérez, A., Rodríguez-Riera, Z. et al. Explaining the interaction of mangiferin with MMP-9 and NF-ƙβ: a computational study. J Mol Model 28, 266 (2022). https://doi.org/10.1007/s00894-022-05260-2
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00894-022-05260-2